Format

Send to

Choose Destination
Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Author information

1
Centre for Rheumatology Research, UCL Division of Medicine, University College London, London.
2
Department of Rheumatology, University Hospitals of Leicester, Leicester.
3
Womens Health, University College London Hospital, London.
4
Obstetrics and Gynaecology, Frimley Park Hospital, Surrey.
5
Department of Rheumatology, University Hospital Birmingham NHS Foundation Trust, Birmingham.
6
Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Department of Rheumatology, Copenhagen University Hospital, Rigshospitalet, Denmark.
7
Department of Rheumatology, Burton Hospitals NHS Trust, Burton-upon-Trent.
8
Rheumatic and Musculoskeletal Disease Unit, Our Lady's Hospice and Care Services, Dublin, Ireland.
9
Department of Rheumatology, University College London Hospital, London.
10
Department of Rheumatology, Aneurin Bevan University Health Board, Newport, UK.
11
Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
12
Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust and Division of Immunity and Infection, University of Birmingham, Birmingham, UK.
13
Centre for Rheumatology Research, UCL Division of Medicine, University College London, London, Womens Health, University College London Hospital, London, i.giles@ucl.ac.uk.

KEYWORDS:

DMARDs; biologics; breastfeeding; corticosteroids; hydroxychloroquine; pregnancy; prescribing; rheumatic disease

PMID:
26750124
DOI:
10.1093/rheumatology/kev404
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center